Hospital stay
Many minimally invasive cases need one to three nights; open or complicated surgery generally needs longer.
Hysterectomy cost in India
The estimate should state why the uterus is being removed, whether the cervix, tubes or ovaries are included, which access route is planned, how adhesions or endometriosis will be handled, and whether suspicious bleeding requires a gynecologic oncologist rather than routine benign surgery.
How much does hysterectomy cost in India?
Planned vaginal or laparoscopic hysterectomy in India commonly costs INR 2,20,000 to 4,50,000 (about USD 2,300 to 4,700). Robotic, difficult endometriosis or large-uterus cases may be INR 4,00,000 to 7,00,000 (USD 4,200 to 7,300), while open, oncologic or multi-organ surgery can exceed INR 4,50,000 to 9,00,000 (USD 4,700 to 9,400).
USD examples use approximately INR 96.22 per USD, near the RBI reference on 15 July 2026. The hospital must issue the final room, route and procedure-specific quote.
Share the basics and the Virello team will guide you toward the next step.
Prefer email? Write to support@virellohealth.com.
Reviewed 2026-07-18
Clinical review: Virello Health Clinical Content Team · Editorial review: Virello Health Research Team
Billing context: INR and USD
Many minimally invasive cases need one to three nights; open or complicated surgery generally needs longer.
Removing the uterus permanently ends the ability to carry a pregnancy, so alternatives deserve discussion when fertility matters.
Hysterectomy does not always remove the ovaries; the ovary and tube plan should be documented before consent.
International patients need a local wound and pathology review before long travel is considered.
Cost at a glance
The scenarios separate routine and complex pathways. They are not fixed packages and should be replaced by a report-led hospital estimate before travel.
| Scenario | INR | USD | Patient and treatment context | Planning scope |
|---|---|---|---|---|
| Planned vaginal or laparoscopic surgery | INR 2,20,000 - 4,50,000 | USD 2,300 - 4,700 | Benign disease, manageable uterine size, no major cancer concern and predictable anatomy. | Models routine surgeon, anesthesia, theatre, short admission and standard pathology within written package limits. |
| Robotic or complex benign surgery | INR 4,00,000 - 7,00,000 | USD 4,200 - 7,300 | Severe endometriosis, prior operations, dense adhesions, obesity, large fibroids or concurrent pelvic repair. | Allows for advanced equipment, longer theatre time and additional specialist support, but each extra procedure must be named. |
| Open or oncology-directed operation | INR 4,50,000 - 9,00,000+ | USD 4,700 - 9,400+ | Very large uterus, suspected malignancy, staging work, bowel or bladder involvement, or a conversion to open surgery. | Requires individualized gynecologic oncology and critical-care assumptions rather than reuse of a benign package. |
Usually included
Total or subtotal hysterectomy by the stated vaginal, laparoscopic, robotic or abdominal route.
Cervix and route must be explicit.
Primary gynecologist, assistants, anesthetist, theatre and ordinary consumables.
Additional specialists may be separate.
Recovery, nursing, routine medicines and room for the included number of days.
Ask for daily overage rates.
Standard examination of removed tissue when included.
Special stains or oncology review may cost more.
Wound, pain, bladder and bowel guidance with written warning signs.
Pathology follow-up date should be booked.
Confirm separately
Ovary or cyst surgery, endometriosis excision, adhesiolysis, prolapse repair or lymph-node staging.
List every possible add-on.
Frozen section, advanced pathology, staging, oncology ICU or further treatment.
Suspicion changes team and scope.
Transfusion, bladder or bowel repair, infection treatment, ICU or readmission.
Ask how non-routine charges are authorized.
Iron infusion, transfusion, diabetes optimization, cardiology clearance or repeat imaging.
Anemia can delay surgery.
Hotel, attendant, meals, local transport and flight changes after discharge.
Include several local recovery days.
Candidate context
Hysterectomy may be considered for persistent heavy bleeding, large or symptomatic fibroids, adenomyosis, prolapse, selected endometriosis, precancer or cancer when conservative treatment is ineffective, unsuitable or not desired. The decision should confirm diagnosis, future pregnancy wishes, alternatives, route feasibility and the consequence of ovary removal.
Symptoms, examination, ultrasound, biopsy and previous treatment should support why definitive surgery is proportionate.
Uterus size, vaginal access, prior cesareans, adhesions, endometriosis and surgeon experience affect the safest approach.
The irreversible loss of uterine fertility and the separate decision about conserving ovaries require clear consent.
Anemia, obesity, diabetes, clot risk, heart disease and anticoagulants influence preparation and admission planning.
Selected bleeding or pain can be managed with medicines or a hormonal intrauterine system.
Fibroid removal, uterine-artery embolization or other uterus-preserving options may suit selected patients.
Ablation, hysteroscopic surgery, pessary or pelvic-floor repair may address a narrower problem.
Procedure variations
Technique, device, medicine, treatment extent, and prior care can change both the clinical plan and the estimate.
The uterus is removed through the vagina without abdominal incisions.
Often preferred when feasible, but anatomy and indication govern selection.
Keyhole instruments allow removal with abdominal visualization.
Ask whether the specimen can be removed safely without unplanned fragmentation.
A robotic platform supports selected minimally invasive operations.
Higher cost is not automatically better for a routine case.
An open incision provides access for very large, complex or oncologic disease.
Recovery and wound burden are generally greater.
City comparison
Only cities with evidence for the procedure should appear here. A city range does not prove that every hospital in that city can manage the same case complexity.
| City | Local range | USD range | Capability context | Stay planning |
|---|---|---|---|---|
| Delhi NCR and Gurugram | INR 2,80,000 - 7,50,000 | USD 2,900 - 7,800 | Strong minimally invasive and gynecologic oncology choices. | Premium rooms and robotics alter the quote. |
| Mumbai | INR 3,00,000 - 8,00,000 | USD 3,100 - 8,300 | Deep support for difficult endometriosis and oncology. | Model higher lodging costs. |
| Bengaluru | INR 2,70,000 - 7,20,000 | USD 2,800 - 7,500 | Broad laparoscopic and robotic availability. | Choose accommodation around follow-up access. |
| Chennai | INR 2,55,000 - 6,80,000 | USD 2,700 - 7,100 | Established gynecology and tertiary surgical backup. | Confirm pathology turnaround. |
| Hyderabad | INR 2,50,000 - 6,60,000 | USD 2,600 - 6,900 | Competitive metro programs for planned surgery. | Compare route-specific packages. |
| Kolkata | INR 2,35,000 - 6,10,000 | USD 2,400 - 6,300 | Eastern access to benign and oncology services. | Confirm blood-bank and ICU scope. |
| Ahmedabad | INR 2,30,000 - 5,90,000 | USD 2,400 - 6,100 | Potential value for stable minimally invasive cases. | Verify surgeon route volume. |
| Pune | INR 2,40,000 - 6,20,000 | USD 2,500 - 6,400 | Practical alternative for western-region patients. | Compare total stay with Mumbai. |
| Indore or Bhopal | INR 2,00,000 - 4,90,000 | USD 2,100 - 5,100 | Good value for selected benign operations with full backup. | Refer complex oncology when depth is limited. |
| Nagpur or Visakhapatnam | INR 2,10,000 - 5,20,000 | USD 2,200 - 5,400 | Suitable for planned cases after capability verification. | Confirm emergency re-operation access. |
Estimate variables
Vaginal, laparoscopic, robotic and open approaches use different equipment and stay assumptions.
The indication should drive the route.
Large fibroids, endometriosis and adhesions increase dissection time and injury risk.
Send imaging and prior notes.
Cervix, tubes, ovaries, cysts, prolapse and adjacent-organ work change the operation.
Consent and price should match.
Abnormal biopsy or imaging can require oncology staging and specialized pathology.
Do not book a benign package first.
Optimization, transfusion planning and specialist clearance add time and cost.
Share current blood results.
Open conversion, urinary retention, bowel delay or fever can add room and investigation charges.
Ask the daily rate.
Medical cost breakdown
Ultrasound with MRI when anatomy, adenomyosis or malignancy remains unclear.
Bring images, not only reports.
Current screening and biopsy for abnormal bleeding when indicated.
Pathology can redirect care.
CBC, iron profile, kidney, liver, glucose, coagulation and anesthesia review.
Correction may precede surgery.
Cardiology, respiratory, hematology or oncology review based on risk.
Not routine for everyone.
Route-specific instruments, energy devices, camera or robotic platform and disposables.
Confirm conversion pricing.
General or regional plan with routine perioperative safety care.
High-risk monitoring may add cost.
Pain control, clot prevention, bladder and bowel monitoring and mobilization.
Room category affects tariffs.
Specimen labeling, standard examination and result review.
Advanced oncology tests are separate.
Checks for bleeding, infection, urinary difficulty, bowel function and pain.
Book before leaving the city.
Explains the final diagnosis and whether further care is needed.
Do not travel without a result plan.
Gradual walking and restrictions on lifting, driving, intercourse and work.
Open surgery usually needs longer.
Menopause counseling if ovaries are removed and pelvic-floor support when needed.
Arrange long-term local care.
Complete journey budget
Patient and attendant costs should be modeled separately from the medical estimate, with flexible dates and a contingency reserve.
Return booking after clinical clearance rather than a fixed post-operative date.
Complications can delay flying.
Accommodation, attendant, food and transport near the hospital.
Mobility-friendly lodging helps.
Reserve for repeat tests, iron treatment or specialist consultations.
Ask what can be done at home.
Local gynecology review, wound support and pathology-directed treatment.
Carry operation and discharge records.
Country access
Visa, donor, fertility, medicine, licensing, and treatment-access requirements can change. Confirm current rules with the relevant authority and treating hospital.
Consent should record the route, cervix, tubes, ovaries, alternatives and possible conversion or adjacent-organ repair.
Removed tissue needs appropriate pathology and a defined way to communicate unexpected findings.
Hospital policy should explain separately billed blood products, special devices and complication care.
International patients should use the current Indian medical visa process and hospital documents.
Hospital selection
Ask how often the surgeon performs the proposed route for comparable anatomy.
General volume can be misleading.
Confirm access to gynecologic oncology when biopsy or imaging is suspicious.
Avoid fragmented referral.
Blood bank, ICU, urology and gastrointestinal surgery should be accessible for complex cases.
Tier 2 quality depends on backup.
Clarify removal method and how possible malignancy affects morcellation decisions.
This is a pre-op question.
Match approach, organ scope, pathology, room days and overage prices.
Compare like with like.
Treating team
Confirms indication, route, organ scope and recovery plan.
Leads when biopsy, imaging or symptoms suggest malignancy.
Optimize anemia, clot, metabolic and cardiopulmonary risks.
Urology, colorectal, physiotherapy or menopause expertise joins when the case requires it.
Hospital comparison guides
Use these report-led guides to compare programme capability, clinical support, city fit, verification questions, recovery planning, and continuity after returning home.
Treatment timeline
Symptoms, imaging, biopsy, screening and prior operations establish the indication.
The surgeon explains alternatives, organ scope, conversion and recovery.
Surgery is followed by pain control, mobilization and bladder and bowel monitoring.
Wound, urinary function and pathology are reviewed before travel.
Activity progresses with local review for concerning symptoms or ongoing pelvic care.
Risks and edge cases
Large vascular fibroids, anemia and difficult dissection raise exposure.
Ask about blood availability.
Prior surgery and endometriosis can distort anatomy.
Complex cases need appropriate backup.
A minimally invasive plan may change for safety.
Consent and cost policy should address this.
Surgery and travel can increase thromboembolism and infection risk.
Follow prevention and warning advice.
Final tissue examination can reveal disease needing oncology review.
Secure rapid pathology handover.
Removing both ovaries before natural menopause can cause abrupt hormone loss.
Discuss benefits, risks and follow-up separately.
Destination comparison
The most suitable destination depends on the individual case, required team, treatment availability, travel route, legal eligibility, budget, and continuity after returning home.
| Decision factor | India | Turkey | Thailand | How to use this |
|---|---|---|---|---|
| Hospital price | Wide city and route-based price range. | Private packages may be quoted in EUR or TRY. | International hospitals may carry higher coordination costs. | Match route, organ scope and stay days. |
| Complex surgery | Several deep minimally invasive and oncology programs. | Selected tertiary centers offer advanced laparoscopy. | Premium centers provide coordinated international care. | Choose the exact surgeon and backup team. |
| Recovery costs | Tier 2 lodging can lower an extended stay. | Travel distance may favor Europe and nearby regions. | Regional access may favor Southeast Asia. | Include post-discharge days, not only hospital price. |
| Continuity | Remote handover is available but needs local gynecology. | Pathology and follow-up pathway varies by center. | International departments often coordinate records. | Confirm pathology timing and home escalation. |
Decision guidance
Planned patients seeking multiple surgical opinions, route choice and metropolitan or value-city options.
Unstable bleeding, severe anemia, suspected urgent cancer or inability to remain for recovery may make travel inappropriate.
Complex endometriosis, oncology, prior pelvic injury or multi-organ work may justify a deeper tertiary center.
Reports for review
Send complete imaging and pathology with a symptom timeline. The quote should be revised if the diagnosis, organ scope or route changes after in-person assessment.
Upload medical reportsThese establish why surgery is proposed.
Recent pelvic ultrasound and MRI images and reports when performed.
Pap or HPV results, endometrial biopsy and prior pathology.
Hormonal therapy, procedures, bleeding response and fertility goals.
These define route and preparation.
Cesarean, myomectomy, endometriosis or abdominal operation notes.
CBC, iron, medicines, allergies, diabetes, clot and heart history.
Previous difficulties, sleep apnea and specialist clearances.
Common questions
Not automatically. The uterus, cervix, tubes, ovaries and any cyst or endometriosis work should be listed separately.
Vaginal surgery may use fewer resources when feasible, but anatomy, diagnosis and surgeon expertise should decide the route.
No. It may help selected complex cases, but a higher platform cost does not guarantee a better result for routine disease.
Many vaginal or laparoscopic cases need one to three nights; open and complex operations can require longer.
A person cannot carry a pregnancy after the uterus is removed. This irreversible effect must be understood before consent.
Not necessarily if functioning ovaries remain, although the individual hormone plan should be discussed.
Routine pathology may be included, but frozen section, advanced stains and oncology review can be separate.
Selected stable benign cases can, provided surgeon experience, blood bank, ICU and emergency specialist backup are verified.
Only after the treating team reviews mobility, wound, bleeding, clot risk and the planned flight duration.
A route change, extra organ work, transfusion, unexpected cancer, complication or additional room days can increase it.
Review and sources
The ranges combine India package observations, expected resource use by access route and city-level cost differences reviewed on 18 July 2026. They assume planned care and must be replaced by an itemized estimate after imaging, pathology, organ scope and medical risk are reviewed.
This page is educational and is not a recommendation to remove the uterus or ovaries. A qualified gynecologist or gynecologic oncologist must confirm the diagnosis, alternatives, route and individual risks.
American College of Obstetricians and Gynecologists · Accessed 2026-07-18
Supports: Indications, routes, ovary considerations and risks.
American College of Obstetricians and Gynecologists · Accessed 2026-07-18
Supports: Fibroid treatment alternatives and hysterectomy context.
American College of Obstetricians and Gynecologists · Accessed 2026-07-18
Supports: Bleeding assessment and non-surgical options.
NHS · Accessed 2026-07-18
Supports: Procedure types, indications and recovery context.
Government of India · Accessed 2026-07-18
Supports: Official travel-document pathway.
Reserve Bank of India · Accessed 2026-07-18
Supports: USD conversion illustration.
Related planning
Review preparation, routes and recovery.
Compare uterus-preserving surgery.
Plan fertility care when pregnancy remains a goal.
Evaluate hospital capability.
Compare specialist experience.
Explore related uterine care.
Prepare imaging and pathology.
Check whether definitive surgery is appropriate.
Coordinate wound and pathology continuity.
Compare route-specific packages.
Questions about an estimate? Email support@virellohealth.com.